Xiaoying Pang

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Genexol-PM, produced by Samyang Company (Korea) is an excellent preparation of paclitaxel (PTX) for clinical cancer treatment. However, it cannot resolve the issue of multidrug resistance (MDR)-a significant problem in the administration of PTX to cancer patients. To increase the efficacy of Genexol-PM against MDR tumors, a mixed micelle capable of serving(More)
ALL RIGHTS RESERVED iv To my parents v Acknowledgments First and foremost I want to thank my advisor Prof. Shyh-Yuan Lee, who has given me tremendous help over the past 3 years. I appreciate his contributions of time, ideas and funding to make my Ph.D. experience productive and stimulating. What I benefited is not only from his broad knowledge and deep(More)
The focus of this project is to predict impending seizure occurrence for epilepsy patients using intracranial EEG recordings. Reliable prediction of seizures can provide the patients with not only warnings but also new therapeutic possibilities. The goal is to correctly differentiate the pre-seizure brain state (the preictal state) from the baseline state(More)
  • 1